why choose us

First received: September 12, 2023

Clinical Trial: Early Detection of Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Neoplasms

Study Type: OBSERVATIONAL


Official Title: An Evaluation of a Circulating Tumor Cell-based Test (TriNetra™-Breast) for Breast Cancer Screening in Women Aged 40 and Above

Brief Summary: The TriNetra™ Breast test is intended for use as a breast cancer screening test that evaluates Circulating Tumor Cells (CTCs) associated with breast cancer.The TriNetra™Breast test should be a useful breast cancer screening option for asymptomatic women 40 years of age and older.This pivotal study is designed to provide evidence of test performance and to demonstrate its safety in the intended use population in the USA.

Read more